Leslie D. Funtleyder - Mar 24, 2025 Form 4 Insider Report for Applied Therapeutics, Inc. (APLT)

Role
Interim Chief Executive Officer and Chief Financial Officer, Director
Signature
/s/ Leslie D. Funtleyder
Stock symbol
APLT
Transactions as of
Mar 24, 2025
Transactions value $
$0
Form type
4
Date filed
3/26/2025, 08:21 PM
Previous filing
Mar 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Award $0 +350K +89.64% $0.00 740K Mar 24, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. One fourth (1/4th) of the compensatory RSUs shall vest on March 24, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory RSUs shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.

Remarks:

Interim Chief Executive Officer and Chief Financial Officer